Voloridge Investment Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-59,113
| Closed | -$2.05M | – | 1696 |
|
|
2022
Q1 | $2.05M | Sell |
59,113
-136,253
| -70% | -$4.72M | 0.01% | 940 |
|
|
2021
Q4 | $5.72M | Sell |
195,366
-223,197
| -53% | -$6.53M | 0.03% | 671 |
|
|
2021
Q3 | $10.7M | Buy |
418,563
+75,387
| +22% | +$1.92M | 0.07% | 407 |
|
|
2021
Q2 | $12M | Buy |
343,176
+58,221
| +20% | +$2.04M | 0.08% | 341 |
|
|
2021
Q1 | $11.6M | Sell |
284,955
-56,628
| -17% | -$2.31M | 0.08% | 311 |
|
|
2020
Q4 | $14.8M | Buy |
341,583
+311,657
| +1,041% | +$13.5M | 0.12% | 199 |
|
|
2020
Q3 | $1.65M | Buy |
+29,926
| New | +$1.65M | 0.01% | 781 |
|
|
2020
Q1 | – | Sell |
-38,423
| Closed | -$3.05M | – | 1494 |
|
|
2019
Q4 | $3.05M | Buy |
+38,423
| New | +$3.05M | 0.06% | 393 |
|
|
2018
Q2 | – | Sell |
-38,806
| Closed | -$1.87M | – | 650 |
|
|
2018
Q1 | $1.87M | Buy |
+38,806
| New | +$1.87M | 0.04% | 286 |
|
|
2017
Q2 | – | Sell |
-90,655
| Closed | -$3.34M | – | 624 |
|
|
2017
Q1 | $3.34M | Buy |
+90,655
| New | +$3.34M | 0.08% | 268 |
|